Dementia

There are 11,099 papers on dementia in aging research: 584 trials and 7,156 observational studies in people, 90 in animals, 5 in cells, 2,675 reviews. The newest story, Nov 16, 2026: “Blood marker and age linked to risk of cognitive impairment”.

Disease

11,099 papers study it13,151 more mention it6,504 findings

MeSH

582 new papers in 30 daysSee all 24,250 papers on dementia

“aspirin allocation was associated with a 3.5-fold reduction in incident dementia versus placebo (hazard ratio [HR]: 0.28, 95% confidence interval [CI]: 0.15 to 0.52)”
Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementiaAlzheimer's & dementia : the journal of the Alzheimer's Association2026doi:10.1002/alz.71817
  • Human trial584
  • Humans7,156
  • Animals87
  • Model organisms3
  • Cells5
  • In silico327

Interventions

40

Bilingualism

no changein humans2

2 studies
  1. Bilingualism was not clearly linked with dementia in humans.

    “bilingualism was not associated with baseline dementia status or conversion to probable dementia”

    Humans

    Bilingualism and Cognitive Aging in Ethnically Diverse Older Adults: Cross-sectional and Longitudinal Evidence from HABS-HD

    PsyArXivPreprint

  2. Bilingualism was not clearly linked with dementia in humans.

    “Bilingualism was not associated with baseline dementia status or conversion to probable dementia”

    Humans

    Bilingualism linked to slower memory decline in older adults

    The journals of gerontology. Series B, Psychological sciences and social sciences

More on Bilingualism

Hearing aids

no changein humans1RR 0.59

1 study
  1. Hearing aids showed no clear effect on dementia in humans (RR, 0.59; 95% CI, 0.25-1.38).

    “As the primary outcome, the 24-month incidence of conversion from MCI to dementia-level impairment did not differ significantly between the intervention group (3.09%; 95% CI, 1.62%-5.74%) and the control group (4.74%; 95% CI, 2.60%-8.29%; RD, −2.07%, 95% CI, −4.74% to 0.61%; RR, 0.59; 95% CI, 0.25-1.38; P =.23”

    Human trial24-month

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

  2. Hearing aids showed no clear effect on dementia in humans (mild cognitive impairment and moderate to severe hearing loss) (RR 0.59 (95% CI, 0.25-1.38)).

    “No significant difference was observed in the primary outcome, in which the conversion rate from MCI to dementia-level impairment was 3.09% (95% CI, 1.62%-5.74%) in the intervention group vs 4.74%”

    Human trialmild cognitive impairment and moderate to severe hearing loss24 monthsn = 703

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

More on Hearing aids

Intensive systolic blood pressure control

no changein humans1downin humans1HR 0.73–0.91

1 study
  1. Intensive systolic blood pressure control showed no clear effect on dementia in humans (APOE ε4 non-carriers) (HR 0.91 (95% CI 0.67-1.23)).

    “and 6.1 vs 6.7 among non-carriers (HR, 0.91; 95% CI, 0.67-1.23; P-interaction = .35)”

    Human trialAPOE ε4 non-carriersSBP goal <120 mm Hgmedian follow-up 5.1 years

    Effect of Intensive vs Standard Blood Pressure Control According to APOE ε4 Genotype: A Secondary Analysis of SPRINT

    medRxiv : the preprint server for health sciencesPreprint

  2. Intensive systolic blood pressure control decreases dementia in humans (APOE ε4 carriers) (HR 0.73 (95% CI 0.51-1.04); 4-year risk difference -1.7% (95% CI -3.4% to 0%)).

    “dementia rates (intensive vs standard) were 9.7 vs 13.2 per 1,000 person-years among ε4 carriers (hazard ratio [HR], 0.73; 95% CI, 0.51-1.04)”

    Human trialAPOE ε4 carriersSBP goal <120 mm Hgmedian follow-up 5.1 years

    Effect of Intensive vs Standard Blood Pressure Control According to APOE ε4 Genotype: A Secondary Analysis of SPRINT

    medRxiv : the preprint server for health sciencesPreprint

More on Intensive systolic blood pressure control

Vaccination

downin humans1

1 study
  1. Vaccination protects against dementia in the context of herpesvirus infections.

    “Moreover, antiviral treatments and vaccinations appear to confer protective effects in this context.”

    Reviewin the context of herpesvirus infections

    Herpesvirus infections and the risk of dementia

    Wiener medizinische Wochenschrift (1946)

More on Vaccination

Antiviral treatment

downin humans1

1 study
  1. Antiviral treatment protects against dementia in the context of herpesvirus infections.

    “Moreover, antiviral treatments and vaccinations appear to confer protective effects in this context.”

    Reviewin the context of herpesvirus infections

    Herpesvirus infections and the risk of dementia

    Wiener medizinische Wochenschrift (1946)

More on Antiviral treatment

Social interaction

downin humans1

1 study
  1. Social interaction protects against dementia in humans.

    “frequent social interaction serves as a protective factor against dementia”

    Review

    Social Isolation and the Risk of Cognitive Decline and Dementia: Implications and Prevention Strategies

    Indian Journal of Social Psychiatry

More on Social interaction

Spousal traumatic brain injury

no changein humans1HR 1.17

1 study
  1. Spousal traumatic brain injury was not clearly linked with dementia in humans (Uninjured spouses; compared with no spousal traumatic brain injury) (HR 1.17, 95% CI 0.88–1.56).

    “but not dementia (HR, 1.17 [95% CI, 0.88-1.56]; P = .28) or MACE (HR, 1.15 [95% CI, 0.84-1.57]; P = .40).”

    HumansUninjured spouses; compared with no spousal traumatic brain injuryMedian follow-up 19.5 yearsn = 6,562

    Spouse’s traumatic brain injury linked to higher death risk

    JAMA network open

More on Spousal traumatic brain injury

Bilateral salpingo-oophorectomy

no changein humans1HR 0.9

1 study
  1. Bilateral salpingo-oophorectomy was not clearly linked with dementia in humans (Non-malignant hysterectomy; compared with ovarian conservation) (HR 0.90, 95% CI 0.65-1.24).

    “BSO was not associated with cardiovascular disease, dementia, or osteoporosis-related fracture in women of postmenopausal age undergoing non-malignant hysterectomy.”

    HumansNon-malignant hysterectomy; compared with ovarian conservationfemales

    Ovary removal at 50–70 with noncancer hysterectomy not tied to 3 risks

    Journal of minimally invasive gynecology

More on Bilateral salpingo-oophorectomy

Intensive blood pressure management

downin humans1

1 study
  1. Intensive blood pressure management decreases dementia in humans.

    “intensive blood pressure management led by non-physician healthcare providers reduced dementia and cognitive impairment.”

    Reviewlong-term follow-up

    Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 European Society of Cardiology Conference

    Current atherosclerosis reports

More on Intensive blood pressure management

Outdoor extreme heat

no changein humans1

1 study
  1. Outdoor extreme heat was not clearly linked with dementia in humans.

    “No associations were found for "Extreme Caution" heat.”

    Humans"Extreme Caution" heat (90°F to 102°F [32.2°C to 39.3°C])5-year exposuren = 28,512

    Extreme heat linked to higher dementia risk in older US adults

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Outdoor extreme heat

PCSK9-targeted therapies

no changein humans1OR 0.77

1 study
  1. PCSK9-targeted therapies showed no clear effect on dementia in humans (OR 0.77 (95% CI 0.14-4.28)).

    “no significant association was observed for the risk of dementia and Parkinson's disease”

    Human trialn = 64,116

    Association between PCSK9 targeted therapy and the risk of stroke and dementia: A meta-analysis of randomized controlled trials

    The American journal of medicine

More on PCSK9-targeted therapies

Anti-obesity medications

no changein humans1RR 1.02

1 study
  1. Anti-obesity medications showed no clear effect on dementia in humans (randomized controlled trials versus placebo) (RR 1.02 (95% CI 0.41 to 2.54)).

    “or dementia (RR = 1.02, 95% CI 0.41 to 2.54, P = 0.97) versus placebo”

    Human trialrandomized controlled trials versus placebon = 35,924

    Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence

    Frontiers in pharmacology

More on Anti-obesity medications

Intensive blood pressure control

no changein humans1HR 1.15

1 study
  1. Intensive blood pressure control showed no clear effect on dementia in humans (advanced CKM (Stages 3-4)) (HR 1.15).

    “No benefit was observed in advanced CKM (probable dementia: HR 1.15; composite: HR 0.97).”

    Human trialadvanced CKM (Stages 3-4)n = 2,931

    Cardiovascular-kidney-metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Intensive blood pressure control

All 40

Effects

9

Mortality

upin humans3HR 2.03

3 studies
  1. Dementia is linked with higher mortality in humans (patients with cancer) (HR 2.03, 95% CI 1.98-2.07).

    “and all-cause mortality (2·03, 1·98-2·07) among patients with cancer and dementia.”

    Humanspatients with cancer

    Pre-existing dementia tied to higher cancer mortality

    The lancet. Healthy longevity

  2. Dementia is linked with higher mortality in humans.

    “Dementia rose from the eighth to the third leading cause of death in the EU-27.”

    Humans1990 to 2023

    Burden of Dementia in Europe, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023

    The Lancet regional health. Europe

  3. Dementia is linked with higher mortality in humans (proximal femur fracture undergoing surgery) (adjusted hazard ratio 1.95; 2-year mortality 62.4% vs 24.0%).

    “Both mild and severe impairment were independently associated with increased mortality (adjusted hazard ratios 1.48 and 1.95, respectively).”

    Humansproximal femur fracture undergoing surgery2 yearsn = 1,579

    Severity of Cognitive Impairment and Mortality After Hip Fracture: Implications for Risk Stratification and Care Allocation

    Journal of clinical medicine

Cancer-specific mortality

upin humans1HR 1.28

1 study
  1. Dementia is linked with higher cancer-specific mortality in humans (patients with cancer) (HR 1.28, 95% CI 1.24-1.31).

    “revealed higher cancer-specific mortality (multivariable-adjusted HR 1·28, 95% CI 1·24-1·31)”

    Humanspatients with cancer

    Pre-existing dementia tied to higher cancer mortality

    The lancet. Healthy longevity

Receipt of invasive coronary reperfusion therapy

no changein humans1

1 study
  1. Dementia was not clearly linked with receipt of invasive coronary reperfusion therapy in humans (Acute coronary syndrome; patients with versus without dementia).

    “No difference in the rate of invasive coronary reperfusion therapy was observed between the two groups.”

    HumansAcute coronary syndrome; patients with versus without dementian = 212

    Association between dementia and short-term outcomes of acute coronary syndrome in very elderly adults

    Tạp chí Y học Việt Nam

Grip strength

downin humans1

1 study
  1. Dementia is linked with lower grip strength in humans (fixed group-status analyses) (β = -0.317 kg/year, p = 1.3 × 10−5).

    “accelerated grip decline (β = -0.317 kg/year, p = 1.3 × 10−5)”

    Humansfixed group-status analyses

    Candidate proteomic indirect-effect signals linking dementia to probable muscle-bone fragility: a UK Biobank cohort study

    Frontiers in medicine

More on Grip strength

Homebound status

mediatesin humans1

1 study
  1. Dementia is linked with homebound status in humans (mediation analysis) (PM 25%, CI: 14.4%-35.7%).

    “dementia (PM 25%, CI: 14.4%-35.7%) had statistically significant share”

    Humansmediation analysisn = 130,195

    Lower health literacy linked to becoming homebound

    Journal of general internal medicine

5-year survival

downin humans1

1 study
  1. Dementia is linked with lower 5-year survival in humans (dementia only) (49.2% vs 73.3% (US), 56.8% vs 77.5% (Mexico)).

    “In the United States, standardized 5-year survival was 73.3% (no condition), 57.9% (diabetes only), 49.2% (dementia only), and 36.6% (dual conditions).”

    Humansdementia only

    Diabetes and dementia linked to lower survival in US and Mexico

    The journals of gerontology. Series B, Psychological sciences and social sciences

Functional recovery

downin humans1

1 study
  1. Dementia is linked with worse functional recovery in humans (mortality 29-32%, home independence 23-52%, complete recovery 5-10% in dementia vs 6-11%, 84-86%, 21-22% without impairment).

    “Younger-old and persons without preinjury cognitive impairment had substantially better recovery”

    Humans6 months

    6-Month Recovery after Mild Traumatic Brain Injury in Older Adults: A TRACK-GERI Study

    medRxiv : the preprint server for health sciencesPreprint

Assistance needs

upin humans1

1 study
  1. Dementia is linked with higher assistance needs in humans (severe dementia) (80% with severe dementia, 20% with moderate dementia).

    “whereas 20% with moderate dementia and 80% with severe dementia required assistance to initiate or complete the task.”

    Humanssevere dementian = 11

    Toothbrushing Ability in Older Adults Across Stages of Cognitive Impairment

    Geriatrics (Basel, Switzerland)

Operational errors

upin humans1

1 study
  1. Dementia is linked with higher operational errors in humans (dementia) (p < 0.05).

    “In contrast, the Dementia-D group showed widespread impairments, such as inconsistent pedal use, increased operational errors, and reduced intersection speeds (p < 0.05).”

    Humansdementian = 63

    Driving performance across the cognitive spectrum in active older adults: A simulator study

    Journal of safety research

Upstream

31

GFAP

mediatesin humans2

2 studies
  1. GFAP is linked with dementia in humans (APOE4-associated risk).

    “circulating GFAP served as a shared protein mediator for ACD, AD and VaD”

    HumansAPOE4-associated riskn = 51,623

    Brain and blood markers link APOE4 to dementia risk

    Research SquarePreprint

  2. GFAP is linked with dementia in humans (edentulism association) (12.0%).

    “GFAP mediated 9.8% and 12.0% of the cognitive impairment and dementia associations”

    Humansedentulism association10-yearn = 4,238

    Blood markers account for a small part of tooth loss–dementia link

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on GFAP

Depression

mediatesin humans2

2 studies
  1. Depression is linked with dementia in humans (chain mediation analysis) (15.1%).

    “depression as a central pathway, accounting for 15.1% of the overall association between MVPA and dementia risk”

    Humanschain mediation analysisn = 42,293

    Causal discovery identifies pathways linking physical activity to dementia risk in the UK BioBank

    arXivPreprint

  2. Depression is linked with dementia in humans (29.29% to 44.78%).

    “Estimated mediation proportions for depressive symptoms ranged from 29.29% to 44.78%.”

    Humans

    Frailty transitions, depressive symptoms, and incident dementia: findings from four longitudinal studies

    Journal of affective disorders

More on Depression

Population ageing

upin humans2

2 studies
  1. population ageing is linked with higher dementia in humans (∼90%).

    “representing ∼90% increases since 1990 despite modest declines in age-standardised prevalence.”

    Humans1990-2023

    Burden of Dementia in Europe, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023

    The Lancet regional health. Europe

  2. population ageing is linked with higher dementia in humans (58.6% increase (602,633 to 955,585)).

    “602,633 (8.89%) in 2016 to 955,585 (9.09%) in 2025, a 58.6% increase.”

    Humans2016-2025

    National Surveillance-Based Retrospective Longitudinal Analysis of Dementia Prevalence Trends in the Republic of Korea, 2016-2025, with a One-Year 2026 Forecast Using National Health Insurance Service Administrative Data

    Journal of clinical medicine

Education, health behaviors, mental health, and cardiovascular health

mediatesin humans1

1 study
  1. education, health behaviors, mental health, and cardiovascular health is linked with dementia in humans (Joint mediation of the association between child abuse and dementia) (Approximately 18% of the association mediated; almost all mediation occurred through mental health).

    “Education, health behaviours, mental health and cardiovascular health mediated approximately 18% of the association.”

    HumansJoint mediation of the association between child abuse and dementian = 5,448

    Potentially modifiable mediators of the association between child abuse and dementia

    European journal of psychotraumatology

Mediterranean Diet Score

no changein humans1

1 study
  1. Mediterranean Diet Score was not clearly linked with dementia in humans.

    “A higher MDS was associated with a lower risk of 20-year dementia morbidity in men (multivariable-adjusted HR=0.83; 95% CI: 0.71-0.96), but not in women.”

    Humans20 yearsfemales

    Sex-specific associations between Mediterranean Diet Score and long-term risk of mortality, dementia and other chronic diseases. 20-year evidence from a Swedish population study of 70-year old individuals

    The journal of nutrition, health & aging

More on Mediterranean Diet Score

Left atrial enlargement

no changein humans1

1 study
  1. Left atrial enlargement was not clearly linked with dementia in humans.

    “but not with dementia or all-cause mortality”

    Humansmedian follow-up of 7.3 yearsn = 10,024

    Enlarged heart chamber linked to higher stroke risk

    Journal of the American Heart Association

Retirement timing

no changein humans1

1 study
  1. retirement timing was not clearly linked with dementia in humans (compared with individuals retiring after full-time work in early-to-mid 60s).

    “Compared with individuals retiring after full-time work in their early-to-mid 60s, dementia risk was similar among those retiring earlier or later from full-time work.”

    Humanscompared with individuals retiring after full-time work in early-to-mid 60sn = 13,879

    Sustained part-time work is linked to lower dementia risk

    medRxivPreprint

Criteria-based probable REM sleep behavior disorder

no changein humans1HR 1

1 study
  1. Criteria-based probable REM sleep behavior disorder was not clearly linked with dementia in humans (memory clinic cohort) (HR 1.00, 95% CI: 0.57–1.76).

    “there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76)”

    Humansmemory clinic cohortmedian follow-up 3.4 yearsn = 619

    Probable REM sleep disorder links to Lewy body dementia

    Alzheimer's research & therapy

More on Criteria-based probable REM sleep behavior disorder

Biological-age acceleration

mediatesin humans1HR 1.0062

1 study
  1. Biological-age acceleration is linked with dementia in humans (childhood/adolescence smoking) (HR 1.0062, 95% CI 1.0002-1.0125; mediated proportion 3.63%).

    “For childhood/adolescence smoking, the combined indirect effect through KDM-BA and PhenoAge acceleration was small (HR = 1.0062, 95% CI 1.0002-1.0125)”

    Humanschildhood/adolescence smokingn = 285,009

    Accelerated biological aging in the association between early-life tobacco smoke exposure and dementia risk: An exploratory mediation analysis

    Journal of Alzheimer's disease : JAD

More on Biological-age acceleration

Extreme responding

no changein humans1

1 study
  1. Extreme responding was not clearly linked with dementia in humans.

    “Extreme responding was not significantly associated with dementia risk.”

    Humansn = 76,350

    Atypical survey response patterns as early indicators of dementia onset: A coordinated analysis across longitudinal aging cohorts

    The journals of gerontology. Series B, Psychological sciences and social sciences

More on Extreme responding

All 31

Associations

500

GLP-1 receptor agonists

downin humans15downin reviews2RR 0.17–0.75

17 studies
  1. GLP-1 receptor agonists are associated with dementia in humans (Adults without diabetes with BMI ≥27 kg/m2; compared with multivitamin use) (RR 0.17, 95% CI 0.15-0.19).

    “GLP-1RA exposure was associated with substantially lower risks of dementia (RR 0.17, 95% CI 0.15-0.19)”

    HumansAdults without diabetes with BMI ≥27 kg/m2; compared with multivitamin use10 yearsn = 57,066

    Certain weight-loss drugs linked to lower dementia risk

    AHA Scientific Sessions 2026 abstract

  2. GLP-1 receptor agonists are associated with dementia in humans (1.2% vs 1.6%; RR 0.75 (95% CI 0.57–0.98); HR 0.87 (95% CI 0.66–1.14), nonsignificant).

    “GLP-1 RA initiation was associated with lower cumulative incidence of dementia compared with DPP-4i initiation (1.2% vs 1.6%; RR, 0.75;95% CI, 0.57-0.98; P=0.04).”

    HumansType 2 diabetes after acute myocardial infarction; compared with DPP-4 inhibitor initiation within 180 days after myocardial infarction3 years

    Post-Myocardial Infarction GLP-1 Receptor Agonist Initiation and Incident Dementia in Type 2 Diabetes: A Propensity-Matched Cohort Study

    AHA Scientific Sessions 2026 abstract

  3. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (compared with other second-line glucose-lowering medications) (HR 0.87; 2.8 fewer events/1000 person-years).

    “dementia (HR = 0.87; 2.8 fewer)”

    Humanscompared with other second-line glucose-lowering medications

    Neuropsychiatric Outcomes Associated With GLP-1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status

    Diabetes, obesity & metabolism

  4. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (compared with DPP-4 inhibitor initiation, in COVID-19 survivors with type 2 diabetes) (HR 0.64 (95% CI 0.58–0.72)).

    “GLP-1RA initiation was associated with a lower hazard of incident dementia (hazard ratio [HR], 0.64; 95% confidence interval [CI], 0.58-0.72)”

    Humanscompared with DPP-4 inhibitor initiation, in COVID-19 survivors with type 2 diabetesup to 6 yearsn = 25,263

    GLP-1 agonists linked to lower dementia risk after COVID-19

    Drug design, development and therapy

  5. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (HR 0.74 (95% CI 0.57 to 0.95)).

    “initiation of GLP-1 RAs versus DPP4i in people with T2D and MCI without dementia was associated with a lower risk of incident dementia”

    Humansversus dipeptidyl peptidase-4 inhibitor initiators in people with type 2 diabetes and mild cognitive impairmentup to 5 yearsn = 1,320

    Drug–dementia link in type 2 diabetes with mild cognitive impairment

    Alzheimer's & dementia (New York, N. Y.)

  6. GLP-1 receptor agonists are associated with dementia in humans (HR 0.84, 95% CI 0.64-1.12).

    “0.84 (95% CI 0.64-1.12) after adjustment for educational attainment, APOE ε4, and non-APOE genetic risk”

    Humansafter adjustment for educational attainment, APOE ε4 and non-APOE genetic risk; little change from unadjusted estimatemean follow-up 4.3 yearsn = 14,364

    Education and Alzheimer Disease Genetic Risk in Associations of GLP-1 Receptor Agonists With Dementia Among Adults With Type 2 Diabetes

    medRxiv : the preprint server for health sciencesPreprint

  7. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (adjusted HR 0.86 (0.75-0.99)).

    “Dementia occurred in 1125 GLP-1 RA users (4.8%) and 1822 non-GLP-1 users (7.8%) (adjusted hazard ratio [HR], 0.86 (0.75-0.99)).”

    Humans1:1 matched cohort vs non-GLP-1 glucose-lowering medications; adults with type 2 diabetes and obesity

    GLP-1 diabetes drugs linked to lower risk of dementia

    European journal of internal medicine

  8. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (versus long-acting insulin in type 2 diabetes) (HR 0.64, 95% CI 0.46-0.89).

    “GLP-1 RA use was associated with significantly lower risk of overall dementia (HR 0.64, 95% CI 0.46-0.89, P=0.0072)”

    Humansversus long-acting insulin in type 2 diabetesn = 10,783

    One diabetes drug class linked to lower dementia risk than insulin

    The journal of prevention of Alzheimer's disease

  9. GLP-1 receptor agonists are linked with a lower risk of dementia in humans (HR 0.66 (95% CI 0.55-0.79)).

    “all-cause dementia (HR 0.66 [0.55-0.79], q < 0.001)”

    Humansn = 28,901

    Some diabetes drugs linked to fewer Alzheimer’s diagnoses

    Biology methods & protocols

  10. GLP-1 receptor agonists are linked with a lower risk of dementia in medically managed idiopathic intracranial hypertension (HR 0.52, 95% CI 0.39-0.69).

    “cognitive decline or dementia, 4.88% versus 8.17%, HR 0.52, 95% CI 0.39-0.69”

    Humansin medically managed idiopathic intracranial hypertension5 yearsn = 3,652

    Glucagon-Like Peptide-1 Receptor Agonist Therapy and Neurocognitive Outcomes in Medically Managed Idiopathic Intracranial Hypertension: A Propensity Score-Matched Cohort Study

    AJNR. American journal of neuroradiology

All 17

More on GLP-1 receptor agonists

Mortality

upin humans13no changein humans1HR 1.304–2.44

14 studies
  1. Dementia is linked with a higher risk of mortality in humans.

    “In 1,991,379 persons, MRRs were higher in dementia, highest in long‐term education, and in more recent birth cohorts.”

    Humans2000–2022

    Dementia linked to more years lost in Danes with more education

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Dementia is associated with mortality in humans (sepsis survivors) (HR 1.304).

    “Neoplasia (hazard ratio [HR], 2.011), liver cirrhosis (HR, 1.562), and dementia (HR, 1.304) were the comorbidities most strongly associated with mortality.”

    Humanssepsis survivorswithin 2 years after hospital discharge

    Sepsis survivors faced high mortality after hospital discharge

    Critical care medicine

  3. Dementia is associated with mortality in humans (compared with females of the same age without diagnosed dementia in Germany) (Up to 11 times higher risk of death).

    “Females diagnosed with dementia had up to 11 times higher risk of death compared to those not diagnosed with dementia at the same age”

    Humanscompared with females of the same age without diagnosed dementia in Germany2016–2021females

    Mortality of people with diagnosed dementia in Germany between 2016 and 2021

    Alzheimer's research & therapy

  4. Dementia is linked with a higher risk of mortality in humans (patients with chronic limb-threatening ischemia undergoing distal bypass) (HR 1.79, 95% CI 1.24–2.59, P=0.002).

    “dementia was independently associated with increased mortality (hazard ratio (HR), 1.79; 95% confidence interval (CI), 1.24–2.59, P=0.002)”

    Humanspatients with chronic limb-threatening ischemia undergoing distal bypassn = 688

    Association between Dementia and Mortality Following Distal Bypass in Patients with Chronic Limb-threatening Ischemia A Retrospective Cohort Study Using a Japanese Nationwide Database

    JVS-Vascular Insights

  5. Dementia is associated with mortality in humans (Outpatients with heart failure; multivariable-adjusted analysis) (HR 2.44; 95% CI 2.40-2.49).

    “Incident dementia was associated with higher multivariable-adjusted hazards of all-cause mortality (HR: 2.44; 95% CI: 2.40-2.49)”

    HumansOutpatients with heart failure; multivariable-adjusted analysis

    Heart failure linked to higher dementia risk at ages 40–80

    JACC. Advances

  6. Dementia is associated with mortality in humans after hip fracture surgery.

    “In the 1-year models, age, male sex, ASA IV status, dementia or cognitive impairment, and lower preoperative hemoglobin levels were independently associated with mortality.”

    Humansafter hip fracture surgery1 year

    Aggregation-Sensitive Mortality Associations and Firth Penalized Logistic Regression After Hip Fracture Surgery: A Retrospective Cohort Study

    Journal of clinical medicine

  7. Dementia is associated with mortality in humans with comorbid sepsis (AAMR 30.8 per 100,000, AAPC 0.20%).

    “Between 1999 and 2020, dementia with comorbid sepsis accounted for 284,645 deaths, yielding an overall AAMR of 30.8 (95% confidence interval: 30.7-30.9). Overall mortality remained stable (AAPC: 0.20%; 95% CI: -0.19 to 0.60).”

    Humanswith comorbid sepsis1999-2020n = 284,645

    Trends and Disparities in Dementia- and Sepsis-Related Mortality in Older U.S. Adults (1999-2020)

    Neuroepidemiology

  8. Dementia is linked with a higher risk of mortality in humans among dementia cases at baseline.

    “Mortality among dementia cases at baseline was significantly greater versus cognitively normal participants.”

    Humansamong dementia cases at baseline

    Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  9. Dementia is linked with a higher risk of mortality in humans (patients undergoing swallowing assessment) (HR 1.83; 95% CI 1.02-3.29; p = 0.044).

    “Dementia was also independently associated with mortality (HR 1.83; 95% CI 1.02-3.29; p = 0.044).”

    Humanspatients undergoing swallowing assessmentn = 107

    Pharyngeal Residue Is Independently Associated With Mortality and Aspiration Events in Patients Undergoing Swallowing Assessment: A Retrospective Cohort Study

    Journal of general and family medicine

  10. Dementia predicts mortality in adults with Down syndrome.

    “The most influential predictors of mortality were any claim for dementia, any claim for pneumonia, re-occurring claim for cardiovascular disease three years before index death, and any claim for heart failure and epilepsy.”

    Humansin adults with Down syndrome11 yearsn = 137,293

    Dementia and pneumonia linked to deaths in Down syndrome

    medRxiv : the preprint server for health sciencesPreprint

All 14

Hypertension

upin humans11downin humans1HR 0.66–1.34

12 studies
  1. Hypertension is linked with a lower risk of dementia in patients with aECAD (HR = 0.66 [0.63-0.68]).

    “non-AD dementia (HR = 0.66 [0.63-0.68])”

    Humansin patients with aECAD

    Hypertension links to lower dementia risk in carotid disease

    Research squarePreprint

  2. Hypertension is linked with a higher risk of dementia in Filipino adults (PAF 23% (4% to 40%)).

    “Filipino, Japanese, and non-Latino White participants aged 60 to 75 years, PAFs (95% CI) were 12% (-3% to 28%), 23% (4% to 40%)”

    Humansin Filipino adults

    Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California

    Alzheimer disease and associated disorders

  3. Hypertension is associated with dementia in humans (chronic kidney disease).

    “whereas hypertension, diabetes, depression, hearing loss, and lower leisure/social activity remained associated with higher risk.”

    Humanschronic kidney diseaseMean follow-up of 13.80 yearsn = 16,083

    Disease susceptibility and risk of dementia in patients with chronic kidney disease: a prospective cohort study based on UK Biobank

    BMC neurology

  4. Hypertension is linked with a higher risk of dementia in humans (PAF 11%).

    “education (19%), hypertension (11%), isolation (13%), and depression (60%).”

    Humans

    Risk factors and population attributable fraction for dementia in American Indians: The Strong Heart Study

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  5. Hypertension is linked with a higher risk of dementia in humans (independent association) (HR 1.24, 95% CI 1.17-1.31).

    “Hypertension was associated with dementia risk (hazard ratio [HR], 1.24; 95% confidence interval [CI], 1.17-1.31; p < 0.001)”

    Humansindependent associationmean of 13.2 yearsn = 218,858

    The interplay between impaired kidney function and hypertension in dementia: A 13-year longitudinal study

    Journal of Alzheimer's disease : JAD

  6. Hypertension is linked with a higher risk of dementia in humans (HR 1.21 [1.11-1.31]).

    “Hypertension was associated with increased dementia risk (hazard ratio[HR] 1.21 [1.11-1.31]).”

    Humansn = 57,912

    Hypertension, internet use, physical activity, and dementia risk in older adults: A multinational prospective cohort study across 31 countries

    Journal of advanced research

  7. Hypertension is linked with a higher risk of dementia in humans (White participants) (HR 1.19-1.34 across risk groups).

    “midlife hypertension was significantly associated with dementia incidence across all genetic risk groups among White participants”

    HumansWhite participantsn = 8,931

    Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study

    Neurology

  8. Hypertension is linked with a higher risk of dementia in low-SES group.

    “hypertension was linked to dementia only in the low-SES group”

    Humansin low-SES groupmedian 14.1-year follow-up

    Socioeconomic disparities in modifiable risk burden and dementia prevention: A prospective cohort study

    The journal of nutrition, health & aging

  9. Dementia is associated with hypertension in humans across diagnostic groups in Kinshasa.

    “Dementia cases show higher rates of hypertension, comorbidities, neuropsychiatric symptoms, smoking, and alcohol use”

    Humansacross diagnostic groups in Kinshasa

    Dementia study in Kinshasa enrolls adults aged 65 and older

    Alzheimer's & dementia. Behavior & socioeconomics of aging

  10. Hypertension raises the risk of dementia in humans.

    “hypertension is associated with a wide spectrum of structural and functional brain changes, being a major risk factor for dementia.”

    Review

    Neuroimaging in Hypertension: A Multifaceted Approach to Investigate the Brain

    Hypertension (Dallas, Tex. : 1979)

All 12

More on Hypertension

APOE

upin humans9mixedin humans2downin humans1+80% higher riskHR 0.87–2.32

11 studies
  1. APOE is associated with dementia in humans (Total sample and people without HIV; rs429358 and rs769449) (rs429358: P = 8.8×10 –18; rs769449: P = 1.48 × 10 –12).

    “Across total sample and people without HIV, three genome-wide significant single nucleotide polymorphisms (SNPs) were identified: rs429358 (gene: APOE , P = 8.8×10 –18 )”

    HumansTotal sample and people without HIV; rs429358 and rs769449

    Genetic links to dementia may differ with HIV status

    AIDS (London, England)

  2. APOE is associated with dementia in humans (Association differs by sex).

    “The association between APOE {varepsilon}4 carrier status and dementia differed by sex (interaction p = 0.027).”

    HumansAssociation differs by sexn = 43,759

    Dementia blood predictors vary by sex and genetic risk

    medRxivPreprint

  3. APOE is linked with a higher risk of dementia in humans (APOE4 carriers, allele dosage-dependent).

    “We revealed graded, allele dosage‐dependent risk elevations for ACD, AD and VaD among APOE4 carriers”

    HumansAPOE4 carriers, allele dosage-dependent

    Brain and blood markers link APOE4 to dementia risk

    Research SquarePreprint

  4. APOE is linked with a higher risk of dementia in Europeans.

    “and larger dementia risk for Europeans.”

    Humansin Europeans

    APOE disease risks and proteomic links vary by ancestry

    medRxivPreprint

  5. APOE is linked with a higher risk of dementia in humans following epilepsy onset, one copy of APOE ε4 (approximately 80% higher risk).

    “carrying one copy of the APOE ε4 allele having an approximately 80% higher risk of dementia after epilepsy”

    Humansfollowing epilepsy onset, one copy of APOE ε4

    APOE ε4 associates with epilepsy, dementia, and higher mortality

    Human genetics

  6. APOE is linked with a higher risk of dementia in humans (poor profile with APOE ε4 carriers vs favorable-profile non-carriers) (HR 2.32, 95% CI 1.73-3.12).

    “Relative to favorable-profile APOE ε4 non-carriers, dementia risk was highest among participants with a poor profile who were APOE ε4 carriers (HR 2.32, 95% CI 1.73-3.12).”

    Humanspoor profile with APOE ε4 carriers vs favorable-profile non-carriers31-year58% femalesn = 14,333

    Dementia polygenic score links to dementia, disability, and death

    medRxiv : the preprint server for health sciencesPreprint

  7. APOE is associated with dementia in humans (exploratory analyses).

    “In exploratory analyses, apolipoprotein E ε4 genotype, thoracic aortic calcium, and plasma neurofilament light chain were associated with incident dementia”

    Humansexploratory analysesmedian of 4.7 yearsn = 730

    Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  8. APOE is associated with dementia in humans (multiplicative interaction) (P for interaction = 0.032).

    “Additionally, a significant multiplicative interaction was observed between APOE-ε4 status and the TyG index (P for interaction = 0.032).”

    Humansmultiplicative interaction

    Triglyceride-Glucose Indices, Genetic Susceptibility, and Incident Dementia Risk Across Early CKM Syndrome Stages: A UK Biobank Prospective Cohort Study

    Research SquarePreprint

  9. APOE is associated with dementia in humans.

    “APOE ε4 carriage was most frequent among participants with dementia”

    Humansn = 292

    An Integrated Model Based on Gut Microbiota and APOE Genotype for Predicting Dementia Risk

    Brain sciences

  10. APOE is linked with a higher risk of dementia in humans (versus neutral APOE ε3ε3) (advanced dementia risk by 5.58 years (q<0.001)).

    “versus neutral APOE ε3ε3, ε4 presence advanced dementia risk by 5.58 years”

    Humansversus neutral APOE ε3ε313.6 yearsn = 224,516

    Associations of lifestyle factors and genetic risk with risk and rate advancement periods of dementia

    Preprint

All 12

More on APOE

Type 2 diabetes

upin humans10upin reviews1HR 2.46–3.79

11 studies
  1. Type 2 diabetes is associated with dementia in humans Following type 2 diabetes diagnosis; compared with individuals without diabetes (1-year cumulative incidence: 0.55% versus 0.40%; 5-year: 2.20% versus 2.05%).

    “The absolute risk of dementia was initially higher among patients with T2D.”

    HumansFollowing type 2 diabetes diagnosis; compared with individuals without diabetes1 and 5 years

    Type 2 diabetes linked to higher early dementia risk

    ESC Congress 2026 abstract

  2. Type 2 diabetes is associated with dementia in humans (HR 2.46, 95% CI 1.37–4.42).

    “nominally higher risk of all-cause dementia (HR 2.46, 95% CI 1.37-4.42)”

    HumansType 2 diabetes with high systolic blood pressure variability versus normoglycemia with low blood pressure variability; nominal associationMedian follow-up 5.1 yearsn = 57,611

    Blood pressure swings linked to death and stroke risk

    medRxivPreprint

  3. Type 2 diabetes is linked with a higher risk of dementia in humans (linked diagnosis records definition) (HR 3.79, 95% CI 3.52-4.09).

    “and dementia (3.79; 95 % CI 3.52-4.09).”

    Humanslinked diagnosis records definition

    Operational definitions of type 2 diabetes influence study population characteristics and outcome associations: Empirical evidence from the UK Biobank

    Diabetes research and clinical practice

  4. Type 2 diabetes is linked with a higher risk of dementia in humans (unfavorable/medium SDOH group) (HR 2.9 (95% CI: 1.8-4.6)).

    “T2D (vs. euglycemia) was significantly associated with higher dementia risk in the unfavorable/medium SDOH group: 2.9 (1.8-4.6) in all”

    Humansunfavorable/medium SDOH group14 years

    Social determinants of health and risk of dementia in people with and without type 2 diabetes - findings from two large national-scale cohorts

    Aging

  5. Type 2 diabetes is linked with a higher risk of dementia in humans.

    “increased diabetes severity, increased medication use, and faster progression to kidney disease is associated with increased risk of dementia.”

    Humans

    The association between type 2 diabetes disease trajectories and dementia incidence

    medRxivPreprint

  6. Type 2 diabetes is associated with dementia in humans.

    “T2DM was associated with increased dementia risk, with a generally stronger association for vascular dementia than for Alzheimer’s disease.”

    Review

    TYPE 2 DIABETES MELLITUS AS A RISK FACTOR FOR DEMENTIA AND ALZHEIMER’S DISEASE: A NARRATIVE REVIEW

    Archiv Euromedica

  7. Type 2 diabetes raises the risk of dementia in humans.

    “Metabolic diseases, including obesity and type 2 diabetes mellitus, are major risk factors for cognitive decline and dementia”

    Review

    Mitohormesis linking metabolic dysfunction and neurodegeneration: implications for dementia and therapeutic strategies

    Frontiers in molecular neuroscience

  8. Type 2 diabetes raises the risk of dementia in humans (compared to individuals without diabetes) (60-70% higher risk).

    “People with type 2 diabetes have a 60-70% higher risk of developing dementia than those without diabetes.”

    Reviewcompared to individuals without diabetes

    Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan

    Diabetologia

  9. Type 2 diabetes raises the risk of dementia in humans.

    “Type 2 diabetes mellitus (T2DM) significantly increases the risk of cognitive impairment and dementia”

    Review

    Type 2 Diabetes Mellitus and Dementia: An Emerging Public Health Challenge

    Journal of Diabetology

  10. Type 2 diabetes raises the risk of dementia in humans.

    “raising patients’ risk of developing cognitive impairment and eventual dementia”

    Review

    Type 2 diabetes in dementia and Alzheimer’s disease: Intertwined global health issues brewing on the horizon

    Exploration of neuroscience

All 11

More on Type 2 diabetes

Depression

upin humans10HR 1.59–2.55

10 studies
  1. Depression is associated with dementia in humans (Institutionalized elderly in Kenya) (r = .253, p < .001).

    “This study observed a positive relationship between depression and dementia ( r = .253, df = 186, p < .001).”

    HumansInstitutionalized elderly in Kenya

    Prevalence of depression and dementia among institutionalized elderly in Kenya: Nairobi county

    Europe's journal of psychology

  2. Depression is linked with a higher risk of dementia in humans (adjusted HR 1.59, 95% CI 1.38–1.85).

    “Postoperative depression was associated with incident dementia (adjusted HR 1.59, 95% CI 1.38–1.85”

    Humansup to 6 years

    New postoperative depression links to higher dementia risk

    Research SquarePreprint

  3. Depression is linked with a higher risk of dementia in humans (overall) (doubled).

    “depression doubled the overall risk of Prb-D.”

    Humansoverall

    Probable dementia varied by race and ethnicity in older adults

    The journal of prevention of Alzheimer's disease

  4. Depression is associated with dementia in humans across all examined European regions.

    “Depression and physical inactivity were consistently associated with dementia across all regions.”

    Humansacross all examined European regionsn = 40,000

    Modifiable Risk Factors for Dementia across the Europe: regional comparative studyusing SHARE data

    Research SquarePreprint

  5. Depression is associated with dementia in humans.

    “Vascular conditions, traumatic brain injury, post-traumatic stress disorder, and depression were associated with risk of dementia among AI/AN veterans.”

    Humansn = 31,341

    Incidence and risk factors for AD/ADRD among American Indian and Alaska Native US Veterans

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  6. Depression is linked with a higher risk of dementia in humans (compared with having neither T1DM nor depression) (HR 2.55, 95% CI 2.22–2.95).

    “depression alone (HR: 2.55 [95% CI: 2.22, 2.95])”

    Humanscompared with having neither T1DM nor depression

    Clinical modifiers of the association between type 1 diabetes and dementia incidence

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  7. Depression is associated with dementia in humans (chronic kidney disease).

    “whereas hypertension, diabetes, depression, hearing loss, and lower leisure/social activity remained associated with higher risk.”

    Humanschronic kidney diseaseMean follow-up of 13.80 yearsn = 16,083

    Disease susceptibility and risk of dementia in patients with chronic kidney disease: a prospective cohort study based on UK Biobank

    BMC neurology

  8. Depression is linked with a higher risk of dementia in humans (PAF 4.6%).

    “Total adjusted PAF was 11.1% led by depression (4.6%), lower education (1.7%), and diabetes (1.6%).”

    Humansn = 83,370

    Diabetes complications linked to dementia in older US adults

    Diabetes research and clinical practice

  9. Depression is linked with a higher risk of dementia in humans (accounting for reverse causation) (PAF 5.7% (95% CI 5.7-5.8)).

    “After accounting for reverse causation, the PAF for hospital-diagnosed infections was 7·0% (95% CI 6·9-7·0), and 5·7% (5·7-5·8) for depression.”

    Humansaccounting for reverse causationn = 1,753,515

    Dementia risk patterns varied across groups in Denmark

    The Lancet. Public health

  10. Depression is linked with a higher risk of dementia in humans (mid-life).

    “The largest proportion of dementia cases was attributable to social isolation, followed by physical inactivity and depression.”

    Humansmid-life

    Population attributable fractions of modifiable dementia risk factors in the Netherlands: a cross-sectional, time series analysis

    EClinicalMedicine

More on Depression

Hearing loss

upin humans8+7% population-attributable fractionHR 1.38

8 studies
  1. Hearing loss is linked with a higher risk of dementia in humans (HR=1.38, p<0.001).

    “HL was associated with higher risk of incident dementia (HR=1.38, p<0.001)”

    Humans11.8 yearsn = 317,108

    Hearing loss and loneliness each linked to dementia

    BMJ public health

  2. Hearing loss is associated with dementia in humans (chronic kidney disease).

    “whereas hypertension, diabetes, depression, hearing loss, and lower leisure/social activity remained associated with higher risk.”

    Humanschronic kidney diseaseMean follow-up of 13.80 yearsn = 16,083

    Disease susceptibility and risk of dementia in patients with chronic kidney disease: a prospective cohort study based on UK Biobank

    BMC neurology

  3. Hearing loss is associated with dementia in humans (Pearson r = 0.827, Spearman rho = 0.845, p < 0.001).

    “The global bivariate association between hearing loss prevalence and dementia prevalence was strong in females (Pearson r = 0.827; Spearman rho = 0.845; p < 0.001)”

    Humansfemales

    Hearing Loss and Dementia Prevalence Across Countries: Global Ecological Evidence in Females and Males

    Dementia (London, England)

  4. Hearing loss raises the risk of dementia in humans.

    “identified midlife hearing loss as one of the largest potentially modifiable risk factors for dementia”

    Review

    The Hearing-Cognition Relationship Across the Lifespan: Mechanisms, Interventions and Outcomes

    Audiology research

  5. Hearing loss raises the risk of dementia in humans (OR = 1.43, 95% CI: 1.21-1.68).

    “Hearing loss was significantly associated with increased risk of cognitive impairment (OR = 1.34, 95% CI: 1.17-1.53) and dementia (OR = 1.43, 95% CI: 1.21-1.68).”

    Review

    The association between hearing loss in adults and cognitive outcomes: an umbrella review and meta-analysis

    Frontiers in aging neuroscience

  6. Hearing loss raises the risk of dementia in humans.

    “the resulting cascade of cognitive, social, and functional decline accounts for a sizable share of preventable dementia risk in later life”

    Review

    Loud Speaking Voice as a Behavioral Marker Supporting Secondary Prevention of the Cascade Consequences of Untreated Hearing Impairment

    Journal of Clinical Medicine Research

  7. Hearing loss raises the risk of dementia in humans (~7% population-attributable fraction).

    “The 2024 Lancet Commission identified hearing loss as the single largest modifiable dementia risk factor (~7% population-attributable fraction).”

    Review

    A Global Burden Perspective on Obstructive Sleep Apnea, Hearing Loss, and Early-Onset Cognitive Decline

    Neurology international

  8. Hearing loss raises the risk of dementia in humans.

    “Hearing loss has been associated with both accelerated cognitive decline and increased dementia risk, with a clear severity-impact relationship.”

    Review

    Hearing Loss and Dementia: Risk Factor, Early Marker, or Both?

    Healthcare (Basel, Switzerland)

More on Hearing loss

Diabetes mellitus

upin humans7HR 1.29–1.43

7 studies
  1. Diabetes mellitus is associated with dementia in humans (Dementia-free at baseline; time-updated analysis) (HR 1.29, 95% CI 1.19–1.41).

    “Diabetes was associated with higher dementia risk in the time-updated analysis (HR, 1.29; 95% CI, 1.19–1.41).”

    HumansDementia-free at baseline; time-updated analysisn = 18,028

    Diabetes linked to higher dementia risk across later life

    Alzheimer's research & therapy

  2. Diabetes mellitus predicts dementia in humans.

    “Additional predictors included being born in the Southeastern U.S., lacking private health insurance, non-veteran status, having poor vision or hearing, limited work history, disability, diabetes, body mass index ≥ 35, prior stroke, and both alcohol abstention and heavy drinking.”

    Humans

    Dementia near 80 linked to health and thinking skills near 60

    AJE advances : research in epidemiology

  3. Diabetes mellitus is linked with a higher risk of dementia in humans (early-onset diabetes, high HbA1c, and high cholesterol levels) (HR 1.43, 95% CI 1.15-1.77).

    “subgroup 3 of diabetes showed a significantly higher risk of dementia (hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.15-1.77)”

    Humansearly-onset diabetes, high HbA1c, and high cholesterol levels

    Associations of diabetes subgroups and lifestyle with incident dementia: insights from unsupervised phenotype clustering analysis

    Frontiers in endocrinology

  4. Diabetes mellitus is associated with dementia in Southern, Western and Central/Eastern Europe.

    “Low education and diabetes were associated with incident dementia in Southern, Western and Central/Eastern Europe but not in Northern Europe.”

    Humansin Southern, Western and Central/Eastern Europe

    Modifiable Risk Factors for Dementia across the Europe: regional comparative studyusing SHARE data

    Research SquarePreprint

  5. Diabetes mellitus is associated with dementia in humans (chronic kidney disease).

    “whereas hypertension, diabetes, depression, hearing loss, and lower leisure/social activity remained associated with higher risk.”

    Humanschronic kidney diseaseMean follow-up of 13.80 yearsn = 16,083

    Disease susceptibility and risk of dementia in patients with chronic kidney disease: a prospective cohort study based on UK Biobank

    BMC neurology

  6. Diabetes mellitus is linked with a higher risk of dementia in humans (PAF 1.6%).

    “Total adjusted PAF was 11.1% led by depression (4.6%), lower education (1.7%), and diabetes (1.6%).”

    Humansn = 83,370

    Diabetes complications linked to dementia in older US adults

    Diabetes research and clinical practice

  7. Diabetes mellitus is linked with a higher risk of dementia in humans (OR 2.14, 95% CI 1.83-2.50).

    “Compared to participants without diabetes, the dementia risk was significantly higher in participants with diabetes (Odds Ratio [OR]: 2.14, 95% Confidence Interval [CI]: 1.83-2.50)”

    Humans10-year period before diabetes

    Dynamic dementia risk before and after incident diabetes mellitus: a combined case-control and cohort study

    BMC public health

More on Diabetes mellitus

Lithium

downin humans6HR 0.38–0.689

6 studies
  1. Lithium is associated with dementia in humans (HR 0.68, 95% CI 0.60–0.76).

    “Lithium initiation was also associated with a lower recorded risk of incident dementia (HR 0.68, 95% CI 0.60-0.76; p < 0.001).”

    HumansIncident dementia following lithium initiation compared with valproate initiation; propensity score-matched groupsn = 22,098

    Starting lithium linked to lower death and dementia risks

    Frontiers in neurology

  2. Lithium is linked with a lower risk of dementia in humans (vs valproate) (HR 0.38, 95% CI 0.24-0.60).

    “All-cause dementia occurred in 25/795 (3.1%) lithium versus 69/832 (8.3%) valproate users (HR, 0.38; 95% CI, 0.24-0.60; P < .001).”

    Humansvs valproatelithium carbonateserum measurements ≤0.40 mmol/L730 days

    Low-dose lithium vs valproate and incident dementia diagnoses in older adults: A propensity-matched cohort study using electronic health record data

    Psychiatry research

  3. Lithium is linked with a lower risk of dementia in adults with bipolar disorder compared with valproate (HR 0.689, 95% CI 0.578-0.822; RR 0.658, 95% CI 0.556-0.778).

    “Lithium use was associated with a lower risk of all-cause dementia than valproate use (207 [7.1%] vs 311 [10.8%]; Relative risk [RR], 0.658; 95% confidence interval [CI], 0.556-0.778; Hazard ratio [HR], 0.689; 95% CI, 0.578-0.822; both P<.001).”

    Humansin adults with bipolar disorder compared with valproate

    Lithium versus valproate in bipolar disorder: Associations with dementia, mortality, suicide attempt, and end-stage renal disease in adults aged 45 years and older - a propensity score-matched retrospective cohort study

    Psychiatry research

  4. Lithium is associated with dementia in humans (bipolar disorder).

    “Lithium carries the most consistent observational signal for reduced dementia risk, with plausible antioxidant and neurotrophic mechanisms”

    Reviewbipolar disorder

    Oxidative Stress, Brain Antioxidant Imaging, and Cognitive Aging in Older Adults With Bipolar Disorder

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  5. Lithium lowers the risk of dementia in humans (HR 0.633, 95% CI: 0.517-0.775).

    “Four cohort studies showed a pooled hazard ratio (HR) of 0.633 (95% CI: 0.517-0.775; p = 0.003), indicating ∼37% lower dementia risk with lithium.”

    Review

    Lithium exposure and risk of dementia and Alzheimer's disease: A systematic review and meta-analysis

    Journal of Alzheimer's disease : JAD

  6. Lithium lowers the risk of dementia in humans (observational cohorts).

    “Observational cohorts also associate lithium exposure with lower dementia incidence”

    Reviewobservational cohorts

    LITHIUM AND ALZHEIMER’S DISEASE: POTENTIAL NEUROPROTECTIVE EFFECTS AND THERAPEUTIC PERSPECTIVES

    International Journal of Innovative Technologies in Social Science

More on Lithium

Exercise

downin humans5upin humans1

6 studies
  1. Exercise is linked with a lower risk of dementia in humans (maintaining or increasing activity) (aHR 0.82, 95% CI 0.75-0.91).

    “maintaining or increasing activity was associated with reduced risk (aHR, 0.82; 95% CI, 0.75-0.91)”

    Humansmaintaining or increasing activity

    Impact of Changes in Physical Activity on Dementia Risk Among Cancer Survivors: A Nationwide Cohort Study Comparing Chemotherapy and Non-Chemotherapy Groups

    Cancer research and treatment

  2. Exercise is linked with a lower risk of dementia in humans.

    “pathways linking higher MVPA to lower dementia risk through depression, functional capacity, smoking behavior, hypertension, cardiovascular disease, chronic kidney disease, and brain injury”

    Humansn = 42,293

    Causal discovery identifies pathways linking physical activity to dementia risk in the UK BioBank

    arXivPreprint

  3. Exercise is associated with dementia in humans (physical inactivity, across all examined European regions).

    “Depression and physical inactivity were consistently associated with dementia across all regions.”

    Humansphysical inactivity, across all examined European regionsn = 40,000

    Modifiable Risk Factors for Dementia across the Europe: regional comparative studyusing SHARE data

    Research SquarePreprint

  4. Exercise is linked with a lower risk of dementia in humans (post-stroke).

    “Regular MAE, not too low LDL-C levels (≥100 mg/dL), or both combined, were associated with a lower risk of progression to incident dementia.”

    Humanspost-stroken = 679

    Interactions between minimal amount of exercise and low-density lipoprotein cholesterol on incident dementia after stroke

    iScience

  5. Exercise lowers the risk of dementia in humans.

    “physical activity is consistently associated with lower risks of cognitive decline, dementia, and Parkinson's disease”

    Review

    Exercise timing as a potential temporal regulator of neurolymphatic physiology in neurodegenerative proteinopathies: a mechanistic framework

    Frontiers in neuroscience

  6. Exercise lowers the risk of dementia in humans.

    “In AD, mid-life physical activity has been associated with reduced dementia risk in epidemiological studies”

    Review

    Psychological and neurological benefits of physical activity: impact on mental health, Parkinson's disease, and Alzheimer's disease

    Brain structure & function

More on Exercise

Aspirin

downin humans2HR 0.28–0.88

2 studies
  1. Aspirin lowers the risk of dementia in Q5 of the PGS distribution (highest quintile for genetically associated platelet count) (HR 0.29, 95% CI 0.16 to 0.55).

    “aspirin use being associated with 3.5‐fold lower dementia risk versus placebo (HR: 0.29, 95% confidence interval [CI]: 0.16 to 0.55, p = 0.0001”

    Human trialin Q5 of the PGS distribution (highest quintile for genetically associated platelet count)median follow‐up of 4.6 years

    Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Aspirin lowers the risk of dementia in humans (highest quintile of platelet-count PGS003548) (HR 0.28, 95% CI 0.15-0.52).

    “aspirin allocation was associated with a 3.5-fold reduction in incident dementia versus placebo (hazard ratio [HR]: 0.28, 95% confidence interval [CI]: 0.15 to 0.52)”

    Human trialhighest quintile of platelet-count PGS003548

    Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. Aspirin is associated with dementia in humans (High ASCVD risk) (HR 0.88, 95% CI 0.77–1.00).

    “Low and high‐dose aspirin among high ASCVD risk had lower dementia”

    HumansHigh ASCVD riskLow-dose

    Aspirin and cholesterol drugs linked to fewer dementia diagnoses

    Journal of the American Heart Association

More on Aspirin

Metformin

downin humans2HR 0.9

2 studies
  1. Metformin lowers the risk of dementia in humans (compared with placebo) (OR 0.40, 95% CI 0.17–0.97).

    “randomization to metformin was associated with a 60% (OR 0.40 [95% confidence interval 0.17, 0.97]) and 62% (OR 0.38 [95% confidence interval 0.16, 0.89]) lower odds of dementia compared with placebo and ILS, respectively”

    Human trialcompared with placeboaverage intervention duration of 3.2 yearsn = 1,483

    Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study

    medRxiv : the preprint server for health sciencesPreprint

  2. Metformin lowers the risk of dementia in humans (compared with placebo) (60% lower odds (OR 0.40 [95%CI 0.17, 0.97])).

    “randomization to metformin was associated with a 60% (OR 0.40 [95%CI 0.17, 0.97]) and 62% (OR 0.38 [95%CI 0.16, 0.89]) lower odds of dementia compared with placebo”

    Human trialcompared with placebo

    Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study

    medRxiv : the preprint server for health sciencesPreprint

  3. Metformin is associated with dementia in humans (Metformin initiation compared with sulfonylurea initiation) (HR 0.90, 95% CI 0.82–1.02).

    “a lower incidence of dementia (HR: 0.90, 95% CI: [0.82, 1.02]).”

    HumansMetformin initiation compared with sulfonylurea initiation

    Metformin linked to lower dementia risk in US health records

    medRxivPreprint

More on Metformin

Intensive blood pressure control

downin humans1HR 0.62

1 study
  1. Intensive blood pressure control lowers the risk of dementia in humans (non-advanced CKM (Stage 2)) (HR 0.62, 95% CI 0.46-0.85).

    “In non-advanced CKM, intensive BP control reduced risks of probable dementia (hazard ratio [HR] 0.62, 95% confidence interval [CI] 0.46-0.85)”

    Human trialnon-advanced CKM (Stage 2)n = 5,632

    Cardiovascular-kidney-metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Intensive blood pressure control

All 500

Trial sponsors

Funding

1,685 grants since 2016

National Institute on Aging$1.32BJapan Society for the Promotion of Science¥2.84BNational Institute of Neurological Disorders and Stroke$180M

Latest

JAMA Neurology

Blood marker and age linked to risk of cognitive impairment

At age 75, estimated five-year risk of mild cognitive impairment was 17% with higher blood marker levels versus 7% with lower levels.At age 75, estimated five-year risk of mild cognitive impairment was 17% with higher blood marker levels versus 7% with lower levels.

Cohort · 1,644 peopleMild cognitive impairment
medRxiv

Blood proteins linked to cognitive response in lifestyle trial

Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.

Preprint: trial in 1,158 peopleInterventions

See all 24,250 papers on dementia